Silencing Apoe with divalent‐siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease.

MLA

Ferguson, Chantal M., et al. “Silencing Apoe with Divalent‐siRNAs Improves Amyloid Burden and Activates Immune Response Pathways in Alzheimer’s Disease.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 20, no. 4, Apr. 2024, pp. 2632–52. EBSCOhost, https://doi.org/10.1002/alz.13703.

APA

Ferguson, C. M., Hildebrand, S., Godinho, B. M. D. C., Buchwald, J., Echeverria, D., Coles, A., Grigorenko, A., Vangjeli, L., Sousa, J., McHugh, N., Hassler, M., Santarelli, F., Heneka, M. T., Rogaev, E., & Khvorova, A. (2024). Silencing Apoe with divalent‐siRNAs improves amyloid burden and activates immune response pathways in Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 20(4), 2632–2652. https://doi.org/10.1002/alz.13703

Chicago

Ferguson, Chantal M., Samuel Hildebrand, Bruno M. D. C. Godinho, Julianna Buchwald, Dimas Echeverria, Andrew Coles, Anastasia Grigorenko, et al. 2024. “Silencing Apoe with Divalent‐siRNAs Improves Amyloid Burden and Activates Immune Response Pathways in Alzheimer’s Disease.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 20 (4): 2632–52. doi:10.1002/alz.13703.